JGA To Offer Generics Information Service Targeting Physicians
This article was originally published in PharmAsia News
Executive SummaryAs a new measure to promote generic drug use, the Japan Generics Association will establish a website to provide generic drug information to physicians and pharmacists starting in April. The website will offer simple tools to compare brand drug costs with generics and savings to patients. JGA hopes the new measure will help expand the generics substitution rate in Japan. The industry group will also provide product information on quality and adverse effects of drugs of its 43 member companies. Currently, the information is only available through each company website. (Click here for more - Japanese language
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January 2020.
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.